Randomized placebo-controlled, double-blind clinical trial of nanoemulsion curcumin in women with aromatase inhibitor-induced arthropathy: an Alliance/NCORP pilot trial
Maryam B. Lustberg(Yale Cancer Center), Timothy W. Synold(St. Jude Children's Research Hospital), Mina S. Sedrak(University of California, Los Angeles), Mitch A. Phelps(The Ohio State University), Patty Fan‐Havard(Kaweah Delta Health Care District), Chidimma Kalu(City of Hope), Ye Feng(City of Hope), Kevin W. Herrera(City of Hope), Kasey Hill(The Ohio State University), F. Lennie Wong(Tianjin Chengjian University), Ni‐Chun Tsai(City of Hope)
Cited by 12
Related Papers
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2014|1.2k
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update
|Journal of Clinical Oncology|2020|1.1k
Geriatric Assessment–Driven Intervention (GAIN) on Chemotherapy-Related Toxic Effects in Older Adults With Cancer
|JAMA Oncology|2021|464
Inherited <i>NUDT15</i> Variant Is a Genetic Determinant of Mercaptopurine Intolerance in Children With Acute Lymphoblastic Leukemia
|Journal of Clinical Oncology|2015|443
Mitigating long-term and delayed adverse events associated with cancer treatment: implications for survivorship
|Nature Reviews Clinical Oncology|2023|296